A Birth Control Gel for Men Could Be Approved Soon (Would You Actually Trust It?)

madman · Saturday at 9:10 AM

00:45:58 Why Semen Analysis Falls Short
01:12:26 Testosterone, Fertility-Safe Options, and Future Technology

Dr. Alexander Pastuszak, leading urologist, fertility scientist, and biotech entrepreneur, dives deep into the science and future of male birth control, the truth about testosterone therapy and male fertility, the efficacy and challenges of current and emerging male contraceptive options, why semen analysis is an outdated tool for fertility assessment, the impact of environmental and lifestyle factors on declining sperm counts, and practical, evidence-based advice for men aiming to protect their reproductive and overall health.

Chapters:

00:00:00 Introduction
00:02:51 Why Male Birth Control Still Isn’t Available
00:09:51 Non-Hormonal Male Contraceptives
00:16:48 Hormonal Male Contraceptives
00:23:28 Safety, Demand, and Timeline
00:29:59 Vasectomy and Reversibility
00:34:12 Sperm Decline and Environmental Factors
00:45:58 Why Semen Analysis Falls Short
01:01:56 Varicoceles, Medications, and Fertility
01:12:26 Testosterone, Fertility-Safe Options, and Future Technology

Paterna Biosciences: Pioneering New Male Fertility Solutions

Male infertility care is lagging. Paterna is changing that with in vitro spermatogenesis. Explore our science and meet the team.

paternabio.com

madman · Saturday at 9:11 AM

Thread 'Igniting Discovery: Contraline and the Future of Reversible Male Contraception'

Mar 8, 2026

In this episode of AUANews Inside Tract, Igniting Discovery, Kevin Eisenfrats, CEO of Contraline and 2025 Innovation Nexus Showcase winner, discusses the development of two novel male contraceptives, a daily hormonal gel (NEST) and a long-lasting, reversible implant (ADAM). He shares insights on clinical progress, regulatory strategy, and advice for innovators navigating the urology startup space through the AUA Innovation Nexus program.

Contraline